New shot aims to tackle blood pressure and cholesterol at once
NCT ID NCT07368608
First seen Jan 29, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study tests an experimental drug called BEBT-701, given as a shot under the skin, for people with mild to moderate high blood pressure and high LDL ("bad") cholesterol. The trial has two parts: a single-dose phase and a multiple-dose phase, and will involve 340 adults aged 18 to 60. The main goals are to check the drug's safety and see how well it lowers blood pressure and cholesterol levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE HYPERTENSION AND ELEVATED LOW-DENSITY LIPOPROTEIN CHOLESTEROL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410013, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.